Screening of Natural Antidiabetic Agents

No abstract is available for this paper.

• Publication year

  2019

• Venue

  Phytochemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/978-981-13-6920-9_11
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Current anti-diabetic agents and their molecular targets: A review.

  2018cited by this paper
• Indexing Natural Products for Their Potential Anti-Diabetic Activity: Filtering and Mapping Discriminative Physicochemical Properties

  2017cited by this paper
• Alloxan-induced diabetes, a common model for evaluating the glycemic-control potential of therapeutic compounds and plants extracts in experimental studies.

  2017cited by this paper
• Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management

  2017cited by this paper
• Computational Discovery and Experimental Confirmation of TLR9 Receptor Antagonist Leads

  2016cited by this paper
• A Comprehensive Review: The use of Animal Models in Diabetes Research

  2016cited by this paper
• Phytochemical and In vitro Antidiabetic Activity of Psidium Guajava Leaves

  2016cited by this paper
• Discovering Novel and Diverse Iron-Chelators in Silico

  2016cited by this paper
• Challenges and issues with streptozotocin-induced diabetes - A clinically relevant animal model to understand the diabetes pathogenesis and evaluate therapeutics.

  2016cited by this paper
• How to Choose the Suitable Template for Homology Modelling of GPCRs: 5‐HT7 Receptor as a Test Case

  2016cited by this paper
• In vitro screening for protein tyrosine phosphatase 1B and dipeptidyl peptidase IV inhibitors from selected Nigerian medicinal plants

  2016cited by this paper
• MODELS TO STUDY IN VITRO ANTIDIABETIC ACTIVITY OF PLANTS: A REVIEW

  2015cited by this paper
• Screening of antidiabetic and antioxidant activities of medicinal plants.

  2015cited by this paper
• Ethanol extract of mango (Mangifera indica L.) peel inhibits α-amylase and α-glucosidase activities, and ameliorates diabetes related biochemical parameters in streptozotocin (STZ)-induced diabetic rats

  2015cited by this paper
• Akt and Rac1 signaling are jointly required for insulin-stimulated glucose uptake in skeletal muscle and downregulated in insulin resistance.

  2014cited by this paper
• Deep Architectures and Deep Learning in Chemoinformatics: The Prediction of Aqueous Solubility for Drug-Like Molecules

  2013cited by this paper
• Effect of streptozotocin-induced diabetes mellitus on the cerebellar cortex of adult male albino rats: histological and immunohistochemical study

  2013cited by this paper
• Indexing molecules for their hERG liability.

  2013cited by this paper
• Comparison of Confirmed Inactive and Randomly Selected Compounds as Negative Training Examples in Support Vector Machine-Based Virtual Screening

  2013cited by this paper
• Long-term streptozotocin-induced diabetes in rats leads to severe damage of brain blood vessels and neurons via enhanced oxidative stress.

  2013cited by this paper
• Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans

  2013cited by this paper
• Comparative modeling and docking studies of p16ink4/Cyclin D1/Rb pathway genes in lung cancer revealed functionally interactive residue of RB1 and its functional partner E2F1

  2013cited by this paper
• The use of animal models in diabetes research

  2012cited by this paper
• Determination of in vitro antidiabetic effects of Zingiber officinale Roscoe

  2012cited by this paper
• Toward the Prediction of FBPase Inhibitory Activity Using Chemoinformatic Methods

  2012cited by this paper
• The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives

  2012cited by this paper
• Molecular property filters describing pharmacokinetics and drug binding.

  2012cited by this paper
• Duodenal–Jejunal Bypass Surgery Does Not Increase Skeletal Muscle Insulin Signal Transduction or Glucose Disposal in Goto–Kakizaki Type 2 Diabetic Rats

  2011cited by this paper
• Metabolite profiles and the risk of developing diabetes

  2011cited by this paper
• Dipeptidyl peptidase‐4 inhibitors in the treatment of type 2 diabetes: a comparative review

  2011cited by this paper
• Antioxidant rich flavonoids from Oreocnide integrifolia enhance glucose uptake and insulin secretion and protects pancreatic β-cells from streptozotocin insult

  2011cited by this paper
• Obesity‐Induced Diabetes in Mouse Strains Treated With Gold Thioglucose: A Novel Animal Model for Studying β‐Cell Dysfunction

  2011cited by this paper
• Sex-dependent hepatic transcripts and metabolites in the development of glucose intolerance and insulin resistance in Zucker diabetic fatty rats.

  2011cited by this paper
• The prevalence of diabetic retinopathy in Faisalabad, Pakistan: a population-based study

  2011cited by this paper
• Assessing Drugs for their Cardio-Toxicity

  2010cited by this paper
• Evaluation of the antidiabetic potential of selected medicinal plant extracts from the Canadian boreal forest used to treat symptoms of diabetes: part II.

  2009cited by this paper
• Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21–29

  2009cited by this paper
• From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus

  2009cited by this paper
• Still in search of a herbal medicine…

  2009cited by this paper
• Streptozotocin, Type I Diabetes Severity and Bone

  2009cited by this paper
• GAPDH binds GLUT4 reciprocally to hexokinase-II and regulates glucose transport activity.

  2009cited by this paper
• The mechanisms of alloxan- and streptozotocin-induced diabetes

  2008cited by this paper
• Identification of Hits and Lead Structure Candidates with Limited Resources by Adaptive Optimization

  2008cited by this paper
• Streptozotocin‐Induced Diabetic Models in Mice and Rats

  2008cited by this paper
• The GLUT4 glucose transporter.

  2007cited by this paper
• Ceramide- and Oxidant-Induced Insulin Resistance Involve Loss of Insulin-Dependent Rac-Activation and Actin Remodeling in Muscle Cells

  2007cited by this paper
• Abnormal glucose metabolism in patients treated with antipsychotics.

  2007cited by this paper
• Animal models in type 2 diabetes research: an overview.

  2007cited by this paper
• Animal models of type 2 diabetes with reduced pancreatic β-cell mass

  2006cited by this paper
• Immunohistochemical and electron-microscopic observation of β-cells in pancreatic islets of spontaneously diabetic Goto–Kakizaki rats

  2006cited by this paper
• Evaluation of clonal herbs of Lamiaceae species for management of diabetes and hypertension.

  2006cited by this paper
• Association between antipsychotic drugs and diabetes

  2006cited by this paper
• Second-Generation (Atypical) Antipsychotics and Metabolic Effects

  2005cited by this paper
• Animal models of diabetes mellitus

  2005cited by this paper
• The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes.

  2005cited by this paper
• LEW.1WR1 rats develop autoimmune diabetes spontaneously and in response to environmental perturbation.

  2005cited by this paper
• Atypical antipsychotics and glucose homeostasis.

  2005cited by this paper
• Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology.

  2004cited by this paper
• Stochastic algorithm for kinase homology model construction.

  2004cited by this paper
• The high-fat diet-fed mouse: a model for studying mechanisms and treatment of impaired glucose tolerance and type 2 diabetes.

  2004cited by this paper
• Risque de diabète sucré sous antipsychotiques atypiques : Thérapeutique

  2004cited by this paper
• Improvement of Insulin Resistance and Insulin Secretion by Water Extracts of Cordyceps militaris, Phellinus linteus, and Paecilomyces tenuipes in 90% Pancreatectomized Rats

  2004cited by this paper
• Glucose transporter and Na+/glucose cotransporter as molecular targets of anti-diabetic drugs.

  2004cited by this paper
• Molecular design and biological activities of protein-tyrosine phosphatase inhibitors.

  2003cited by this paper
• The effects of traditional antidiabetic plants on in vitro glucose diffusion

  2003cited by this paper
• The Diabetes-Prone NZO/HlLt Strain. I. Immunophenotypic Comparison to the Related NZB/BlNJ and NZW/LacJ Strains

  2002cited by this paper
• A stochastic algorithm for global optimization and for best populations: A test case of side chains in proteins

  2002cited by this paper
• Molecular target structures in alloxan-induced diabetes in mice.

  2002cited by this paper
• DRUG DISCOVERY AND EVALUATION

  2002cited by this paper
• Low Dose Streptozotocin-Induced Diabetes in Rat Insulin Promoter-mCD80-Transgenic Mice Is T Cell Autoantigen-Specific and CD28 Dependent1 2

  2001cited by this paper
• Early development of beta-cells is impaired in the GK rat model of type 2 diabetes.

  2001cited by this paper
• The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas.

  2001cited by this paper
• High-fructose diet decreases catalase mRNA levels in rat tissues

  2001cited by this paper
• The importance of the β-cell in the pathogenesis of type 2 diabetes mellitus

  2000cited by this paper
• A novel energy‐based stochastic method for positioning polar protons in protein structures from X‐rays

  2000cited by this paper
• Intraperitoneally implanted artificial pancrease with transkaryotic beta-cells on microcarrier beads in a diffusion chamber improves hyperglycemia after 90% pancreatectomy in rats.

  2000cited by this paper
• Chapter 19. Recent advances in therapeutic approaches to type 2 diabetes

  2000cited by this paper
• Constitutive differences in antioxidant defense status distinguish alloxan-resistant and alloxan-susceptible mice.

  1999cited by this paper
• Role of protein tyrosine phosphatase-1B in diabetes and obesity.

  1999cited by this paper
• GLUT4 translocation by insulin in intact muscle cells: detection by a fast and quantitative assay

  1998cited by this paper
• Reversal of diet-induced obesity and diabetes in C57BL/6J mice.

  1998cited by this paper
• Drug Discovery and Evaluation: Pharmacological Assays

  1997cited by this paper
• Are animal models of diabetes relevant to the study of the genetics of non-insulin-dependent diabetes in humans?

  1997cited by this paper
• Effects of experimental diabetes and insulin on smooth muscle functions.

  1996cited by this paper
• The structure of human pancreatic α‐amylase at 1.8 Å resolution and comparisons with related enzymes

  1995cited by this paper
• Animal models in diabetes research.

  1994cited by this paper
• On the pathogenesis of IDDM

  1994cited by this paper
• Role of Ca2+ in alloxan-induced pancreatic β-cell damage

  1994cited by this paper
• Direct association of adenosine deaminase with a T cell activation antigen, CD26.

  1993cited by this paper
• Inhibition of Rat Small Intestinal Sucrase and α-Glucosidase Activities by Tea Polyphenols.

  1993cited by this paper
• Hereditary diabetes in the KK mouse: an overview.

  1988cited by this paper
• Mechanism of action of diabetogenic zinc-chelating agents. Model system studies.

  1985cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Determinants of the selective toxicity of alloxan to the pancreatic B cell.

  1982cited by this paper
• The Spontaneous-Diabetes Rat: A Model of Noninsulin Dependent Diabetes Mellitus

  1981cited by this paper
• The Effect of Streptozotocin‐Induced Diabetes in Rats on Cardiac Contractile Proteins

  1981cited by this paper
• Studies on Streptozotocin Diabetes

  1976cited by this paper
• Studies of the Diabetogenic Action of Streptozotocin.∗

  1967cited by this paper
• Streptozotocin, a new antibacterial antibiotic.

  1959cited by this paper
• NECROSIS OF ISLETS OF LANGERHANS PRODUCED EXPERIMENTALLY

  1943cited by this paper

• Drug repurposing for SARS-CoV-2 (COVID-19) treatment

  2022cites this paper
• Molecular optimization of phytochemicals into antidotes

  2021cites this paper
• Pathophysiology of Obesity and Diabetes

  2021cites this paper